Cited by 32Computational Drug Discovery MethodsGene expression and cancer classificationBioinformatics and Genomic Networks

DeepCOP: deep learning-based approach to predict gene regulating effects of small molecules

Woo, Godwin, Fernandez, Michael, Hsing, Michael, Lack, Nathan A, Cavga, Ayse Derya, Cherkasov, Artem·2020·Bioinformatics

Abstract

Motivation: Recent advances in the areas of bioinformatics and chemogenomics are poised to accelerate the discovery of small molecule regulators of cell development. Combining large genomics and molecular data sources with powerful deep learning techniques has the potential to revolutionize predictive biology. In this study, we present Deep gene COmpound Profiler (DeepCOP), a deep learning based model that can predict gene regulating effects of low-molecular weight compounds. This model can be used for direct identification of a drug candidate causing a desired gene expression response, without utilizing any information on its interactions with protein target(s). Results: In this study, we successfully combined molecular fingerprint descriptors and gene descriptors (derived from gene ontology terms) to train deep neural networks that predict differential gene regulation endpoints collected in LINCS database. We achieved 10-fold cross-validation RAUC scores of and above 0.80, as well as enrichment factors of >5. We validated our models using an external RNA-Seq dataset generated in-house that described the effect of three potent antiandrogens (with different modes of action) on gene expression in LNCaP prostate cancer cell line. The results of this pilot study demonstrate that deep learning models can effectively synergize molecular and genomic descriptors and can be used to screen for novel drug candidates with the desired effect on gene expression. We anticipate that such models can find a broad use in developing novel cancer therapeutics and can facilitate precision oncology efforts. Supplementary information: Supplementary data are available at Bioinformatics online.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bioinformatics/btz645

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • QSAR descriptors and GO terms can be combined within a unified QSAR model capable of predicting the effect of a given molecule on a particular gene.

    “QSAR descriptors and GO terms can be combined within a unified QSAR model capable of predicting the effect of a given molecule on a particular gene.129”

    From QSAR without borders (2020) · cites this paper as [129]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Woo, G., Fernandez, M., Hsing, M., Lack, N. A., Cavga, A. D., & Cherkasov, A.
Affiliations
  • University of British Columbia (CA)
  • Department of Urologic Sciences, Faculty of Medicine, Vancouver Prostate Centre, University of British Columbia , Vancouver, British Columbia V6H 3Z6, Canada
  • Koç University (TR)
  • Chemical and Biological Engineering, Koç University , Rumelifeneri Yolu, Istanbul 34450, Turkey
Corresponding author
Cherkasov, Artem
Venue
Bioinformatics
Published
2019-08-26
Volume
36
Issue
3
Pages
813-818
ISSN
  • 1367-4803 (ISSN-L)
  • 1367-4811
OpenAlex
W2970852745
Cited by
32
References
2
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 7 · 2021: 7 · 2020: 5 · 2019: 1
FWCI
3.40
Type
journal article
Language
en
Open access
closed
Locations
  • Bioinformatics (publishedVersion)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research (#156094, #390757)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
Keywords
chemogenomics, deep neural network, molecular fingerprints, differential gene expression, androgen receptor antagonists, precision oncology, drug candidate screening
MeSH terms
Deep Learning, Humans, Male, Neoplasms, Pilot Projects, Precision Medicine, Gene Ontology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review